Nov 5, 4:16 PM ET
AMN Healthcare reported third-quarter 2026 revenue of $717.3 million, up 13% from a year earlier, with GAAP diluted EPS of $0.83 versus $0.76 and adjusted diluted EPS of $1.16 versus $0.39. The company guided fourth-quarter revenue to $655 million to $670 million, 10-12% below the prior year, with operating margin of (0.1%) to 0.5%, so shareholders face a sharp expected slowdown after a quarter boosted by labor disruption revenue.
- Q3 2026 revenue $717.3 million, up 13% year over year; GAAP net income $33.4 million
- GAAP diluted EPS $0.83 vs $0.76 a year ago; adjusted diluted EPS $1.16 vs $0.39
- Q3 labor disruption revenue $59 million vs $12 million in Q3 2025
- Q4 2026 guidance: revenue $655-670 million, operating margin (0.1%) to 0.5%, labor disruption revenue assumed at $5 million vs $124 million in Q4 2025
Read the filing on SEC.gov ↗
May 4, 8:00 AM ET
At its annual meeting on May 1, 2026, AMN Healthcare shareholders elected nine directors, approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan, approved executive pay on an advisory basis, and ratified KPMG LLP as auditor for fiscal 2026. A shareholder proposal calling for an independent board chairman was not approved. The filing reports voting results and does not report financial results.
- Equity plan amendment approved: 28,909,689 for and 895,750 against.
- Independent board chairman proposal not approved: 7,495,013 for and 22,327,804 against.
- Advisory vote on named executive officer pay approved: 22,728,186 for and 7,071,111 against.
- KPMG LLP ratified as independent registered public accounting firm for the year ending December 31, 2026: 33,170,877 for and 1,064,827 against.
Read the filing on SEC.gov ↗
Feb 5, 9:24 AM ET
AMN Healthcare said director R. Jeffrey Harris will retire from the Board at the 2026 annual meeting and will not stand for re-election, stating the decision was not due to any disagreement. The Board intends to nominate Eric Palmer, former Cigna Group executive, for election at that meeting.
- R. Jeffrey Harris informed the Board on January 30, 2026 of his decision to retire, effective at the 2026 annual meeting of shareholders
- Harris's decision was not due to any disagreement with the Company or the Board
- The Board intends to nominate Eric Palmer for election at the 2026 Annual Meeting
- Palmer previously served as President and CEO of Evernorth Health Services from January 2022 to March 2025
Read the filing on SEC.gov ↗
Nov 6, 4:18 PM ET
AMN Healthcare reported third quarter 2025 revenue of $634.5 million, down 8% from a year earlier, and GAAP net income of $29.3 million, or $0.76 per diluted share, versus $0.18 a year earlier. GAAP profit included a $39.2 million gain on the sale of Smart Square, and adjusted diluted EPS fell 36% to $0.39, so shareholders face a mixed picture. The company guided fourth quarter revenue to $715 million to $730 million, 1% to 3% below the prior year.
- Q3 2025 revenue $634.5 million, down 8% year over year; adjusted EBITDA $57.5 million, down 22%
- GAAP diluted EPS $0.76 versus $0.18 a year earlier; adjusted diluted EPS $0.39 versus $0.61
- Q3 income from operations included a $39.2 million gain on the sale of Smart Square
- Q4 2025 guidance: revenue $715 million to $730 million, 1% to 3% lower than the prior year
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.